Verified Partner

Shanghai · China·Founded in 1907

Ruijin Hospital

Pioneered the ATRA + arsenic trioxide combination therapy for acute promyelocytic leukaemia, raising 5-year survival from ~10% to over 97%

one of modern China's most cited medical breakthroughs

Class 3A (三级甲等)DNV DIAS International Accreditation (2025)

View Treatments

Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, was founded in 1907 and has grown into a leading Class 3A academic medical centre with close to 2,800 beds across three campuses in Shanghai. It is internationally recognised in haematology: physician-scientists at Ruijin — including Wang Zhenyi, Chen Zhu, and Chen Saijuan — developed the combined all-trans retinoic acid (ATRA) and arsenic trioxide therapy for acute promyelocytic leukaemia, raising five-year survival from roughly 10% to over 97% and reshaping leukaemia treatment worldwide. The hospital completed a DNV DIAS international accreditation audit in 2025, recognised by insurers in more than 130 countries, and also maintains strong programmes in endocrinology and minimally invasive gastrointestinal surgery.

Overview Specialties Accreditations FAQ

About

Recognition & Awards

Pioneered the ATRA + arsenic trioxide combination therapy for acute promyelocytic leukaemia, raising 5-year survival from ~10% to over 97% — one of modern China's most cited medical breakthroughs

Free guidance

Plan your treatment

Our coordinators match you to the right specialist, arrange your itinerary, and stay with you through recovery — at no cost.

or message us on WhatsApp

No commitment required. Your data is never shared.

At a glance

Hospital overview

calendar_today

1907

Year founded

Over 119 years of experience

verified

Accreditations

Class 3A (三级甲等) · DNV DIAS International Accreditation (2025)

Medical expertise

Specialties at Ruijin Hospital

medical_servicesHaematologist medical_servicesOncologist medical_servicesEndocrinology medical_servicesGastroenterologist

Click a specialty to browse related treatments and cost comparisons.

Quality assurance

Accreditations & Certifications

Accreditations represent independent verification that this hospital meets internationally recognised standards for patient safety, clinical outcomes, and quality management.

Class 3A (三级甲等)

DNV DIAS International Accreditation (2025)

Questions & answers

Frequently asked questions

Click 'Get a Quote' and complete the short form. A CureSureMedico coordinator will contact you within 48 hours with pricing, specialist availability, and next steps — at no charge to you.

Explore more

Other hospitals in the same region

Peking University People's Hospital

Beijing, China

Peking University People's Hospital opened in 1918 as Peking Central Hospital, the first general hospital in China to be entirely Chinese-financed and Chinese-run, and today serves as the Second Clinical Medical School of Peking University with over 2,600 beds and 1,300 physicians across its campuses. Its Institute of Hematology, established in 1981, is where academician Lu Daopei performed China's first successful allogeneic bone marrow transplant and has ranked first nationally in haematology for eleven consecutive years. The hospital's orthopaedics department, founded in 1944 by Feng Chuanhan — founder of the Chinese Orthopaedic Association — operates one of the largest bone tumour centres of its kind internationally.

✓Class 3A (三级甲等)

1,300+

Specialists

2,600+

Beds

View Profile

Shanghai Tongji Hospital

Shanghai, China

Shanghai Tongji Hospital is a Class 3A teaching hospital affiliated with Tongji University School of Medicine, operating close to 1,300 beds across its Putuo District campus in Shanghai. It holds municipal top-priority discipline status in orthopaedics and in psychiatry and neurology, with additional recognised strengths in cardiology, spine surgery, psychosomatic medicine, and gastroenterology.

✓Class 3A (三级甲等)

1,300+

Beds

View Profile

Shanghai GoBroad Cancer Hospital

Shanghai, China

Shanghai GoBroad Cancer Hospital, part of GoBroad Healthcare Group, opened in October 2023 in the Shanghai (Waigaoqiao) Free Trade Zone as the zone's first research-type hospital. The 406-bed Phase I facility (with a further expansion to roughly 700 beds planned by 2026) specialises in solid-tumour oncology, including digestive cancers, bone and soft-tissue sarcoma, and lung cancer, alongside cellular and targeted-therapy programmes.

✓Licensed Class 3 specialty…

406+

Beds

View Profile

No fees. No commitment.

Ready to plan your treatment?

We are compensated by our partner hospitals — never by patients. You get independent clinical matching, full cost transparency, and end-to-end coordination at no cost to you.

Message us on WhatsApp